What is the protocol for oral (per os, PO) loading of amiodarone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Amiodarone Loading Protocol

For ventricular arrhythmias, load with 800-1600 mg daily in divided doses until a cumulative total of 10 grams is reached, then transition to maintenance dosing of 200-400 mg daily. 1, 2

Loading Dose Regimens by Indication

Ventricular Arrhythmias

  • Start with 800-1600 mg per day in divided doses until a total cumulative dose of 10 grams has been administered 1, 2
  • This typically takes 6-14 days depending on the daily dose selected 2
  • Higher loading doses (up to 1200 mg daily) may be used in monitored inpatient settings, though this increases adverse effect risk 1

Atrial Fibrillation

  • Use 600-800 mg per day in divided doses until a cumulative total of 10 grams is given 1
  • After reaching 10 grams total, reduce to maintenance dose of 200 mg daily 1

Alternative Loading Approach

  • A more conservative regimen of 400-600 mg daily in divided doses for 2-4 weeks can be used, followed by maintenance of 100-200 mg daily 1
  • This approach may be preferred for less urgent situations or outpatient loading

Transitioning from IV to Oral Amiodarone

The oral dose depends on duration of prior IV therapy 1, 3:

  • IV therapy <1 week: Start 800-1600 mg oral daily 1, 2
  • IV therapy 1-3 weeks: Start 600-800 mg oral daily 1, 2
  • IV therapy >3 weeks: Start 400 mg oral daily 1, 2

This accounts for the 50% bioavailability of oral amiodarone and ensures comparable total body drug delivery 3

Critical Monitoring During Loading

Cardiovascular Monitoring

  • Watch for bradycardia, QT prolongation, hypotension, and heart block throughout the loading phase 1
  • These effects can occur early despite the drug's long half-life 1

Dose Adjustment Strategy

  • Reduce dose if side effects occur rather than discontinuing therapy when possible 1
  • The frequency of adverse effects correlates directly with total amiodarone exposure (both dose and duration) 2
  • Use the lowest effective dose to minimize toxicity 2

Long-term Toxicity Surveillance

  • Monitor for pulmonary toxicity (cough, dyspnea, interstitial infiltrates), thyroid dysfunction, and hepatic toxicity during and after loading 1, 2
  • Pulmonary toxicity is the most serious potential adverse effect 2

Important Clinical Considerations

Timing of Antiarrhythmic Effect

  • Full antiarrhythmic effect may take days to weeks to develop despite adequate serum levels, due to amiodarone's very long half-life 1
  • However, some electrophysiologic effects can be seen within 24-48 hours with high-dose loading 4

Drug Interactions

  • Avoid coadministration with other QT-prolonging medications without expert consultation 1
  • Reduce warfarin dose by one-third to one-half when starting amiodarone, as it increases prothrombin time by 100% after 3-4 days 3
  • Reduce digoxin dose by approximately 50% or discontinue, as amiodarone increases serum digoxin by 70% after one day 3
  • Avoid grapefruit juice, which increases amiodarone AUC by 50% and Cmax by 84% 3

Concomitant Antiarrhythmic Therapy

  • When adding amiodarone to existing antiarrhythmic therapy, reduce the dose of the other agent by 30-50% several days after starting amiodarone 3
  • For quinidine or procainamide specifically, reduce dose by one-third 3

Common Pitfalls to Avoid

  • Do not use drop counter infusion sets if transitioning from IV, as surface properties can lead to 30% underdosing 3
  • Do not exceed 2 mg/mL concentration for peripheral IV administration to avoid phlebitis 3
  • Side effects are nearly universal (93% of patients in one study), so anticipate and manage them proactively rather than discontinuing therapy prematurely 5
  • The narrow therapeutic window means careful dose titration is essential—the first sign of antiarrhythmic failure may be sudden cardiac death 5

References

Guideline

Amiodarone Loading Dose Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amiodarone Dosage Guidelines for Stable Ventricular Tachycardia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Toxic and therapeutic effects of amiodarone in the treatment of cardiac arrhythmias.

Journal of the American College of Cardiology, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.